DJ-927 and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Status:
Completed
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as DJ-927 and capecitabine, use different ways to
stop tumor cells from dividing so they stop growing or die. Combining more than one drug may
kill more tumor cells.
PURPOSE: This phase I trial is studying the side effects and best dose of DJ-927 and
capecitabine in treating patients with locally advanced or metastatic solid tumors.